JAK2 and metabolic dysfunction-associated steatotic liver disease: It has been identified that circSCD1 stimulates protein expression of JAK2 and STAT5 and ultimately affects the pathogenesis of NAFLD by promoting hepatic steatosis via the JAK2/STAT5 pathway (43).